Evaluation of Cost of Nosocomial Infection (ECONI) Phase 2 and 3
Research type
Research Study
Full title
Evaluation of Cost of Nosocomial Infection (ECONI) -Socioeconomic Impact of HAI and modelling for future investment in Infection Prevention and Control measures in NHSScotland
IRAS ID
196682
Contact name
Jacqui Reilly
Contact email
Sponsor organisation
Glasgow Caledonian University
Clinicaltrials.gov Identifier
14-154, RIE ID
Duration of Study in the UK
2 years, 2 months, 23 days
Research summary
Healthcare Associated Infection (HAI) or Nosocomial Infection (NI) is costly to the NHS and distressing to patients. A Healthcare Associated Infection (HAI) is defined as any infection that occurs two days or more after admission to hospital or present on admission originating in another hospital or is associated with a device or surgical procedure. The impact of these infections is additional cost of treatment, increase length of stay, reduction in quality of life and cost to society. These costs and effect on patient quality of life are not fully described. ECONI will investigate the cost and impact of Healthcare Associated Infection (HAI) to patients, the health service and the wider community. Identifying the patients who are at highest risk of infection, and the infection types which cause the greatest burden will identify areas where interventions would have the greatest impact. All patients who are admitted to two study hospitals will be potentially eligible. The study will be conducted in Edinburgh Royal Infirmary, a large teaching hospital and Hairmyres Hospital, a large general hospital. In hospital recruitment and data collection will continue for one year. Patients who consent to participate will complete a questionnaire about their job, health, caring requirements and responsibilities, and risk factors for HAI at the time of recruitment and a short quality of life questionnaire before they leave hospital. Phase 3 is a longitudinal follow up study will involve consented patient being asked to complete questionnaires, one, three, six and twelve months after they leave hospital. A small number (20-30) of patients who develop HAI will be invited to take part in an interview to ask about their experience in more detail. This application describes Phase 2 and 3 (covered in this submission). An application is being made to PBAP to allow linkage to surveillance data collected in Phase 1 (HAI type and causative organism).
REC name
Scotland A: Adults with Incapacity only
REC reference
16/SS/0199
Date of REC Opinion
3 Feb 2017
REC opinion
Further Information Favourable Opinion